In recent years, the traditional view of the hemostatic system as being regulated by a
coagulation factor cascade coupled with platelet activation has been increasingly …

Deep vein thrombosis (DVT) is a major health problem that requires improved prophylaxis
and treatment. Inflammatory conditions such as infection, cancer, and autoimmune diseases …

Targeted drug delivery to disease-associated activated neutrophils can provide novel
therapeutic opportunities while avoiding systemic effects on immune functions. We created a …

Venous thromboembolism (VTE) encompasses deep-vein thrombosis (DVT) and pulmonary
embolism. VTE is the leading cause of lost disability-adjusted life years and the third leading …

Deep vein thrombosis and pulmonary embolism are a significant health care concern,
representing a major source of mortality and morbidity. In order to understand the …

Venous thromboembolism is a very common and costly health problem worldwide.
Anticoagulant treatment for VTE is imperfect: all have the potential for significant bleeding …

Platelet–leukocyte interactions define a basic cell process that is characterized by the
exchange of signals between platelets and different types of leukocytes and that bridges 2 …

The blood coagulation cascade is essential for haemostasis, but excessive activation can
cause thrombosis. Importantly, recent studies have identified factors that contribute to …

Deep venous thrombosis is a frequent, multifactorial disease and a leading cause of
morbidity and mortality. Most of the time deep venous thrombosis is triggered by the …

Background Team-based learning (TBL) has been adopted as a new medical pedagogical
approach in China. However, there are no studies or reviews summarizing the effectiveness …